Search

Your search keyword '"van Wezel, Tom"' showing total 510 results

Search Constraints

Start Over You searched for: Author "van Wezel, Tom" Remove constraint Author: "van Wezel, Tom" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
510 results on '"van Wezel, Tom"'

Search Results

1. Germline variant affecting p53β isoforms predisposes to familial cancer

4. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas

7. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study

12. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

14. RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer

16. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation

18. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing

19. Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing

21. BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

22. Impact of genetic counselling strategy on diagnostic yield and workload for genome sequencing-based tumour diagnostics

24. Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13

25. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas

26. Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis

28. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

29. Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development

30. Clinicogenomic associations in childhood Langerhans cell histiocytosis:an international cohort study

31. QPOLE:A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

32. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas

33. Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting.

35. Specific (sialyl-)Lewis core 2 O-glycans differentiate colorectal cancer from healthy colon epithelium

36. Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

37. Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk

38. Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

39. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

40. Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring

41. BRAFV600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

42. BRAFV600Eis associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

43. Specific (sialyl-)Lewis core 2 O-glycans differentiate colorectal cancer from healthy colon epithelium

44. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome

45. Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk

47. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome

49. Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib

50. Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC

Catalog

Books, media, physical & digital resources